论文部分内容阅读
海南农垦第一医院传染科继今年初在国内首次把同种异体肝细胞移植治疗重症肝炎通过鉴定之后,他们为解决供体肝细胞以满足临床需要,进一步设计了异种肝细胞移植治疗重症肝炎的科研新课题。经过多次对动物试验,制成《异种肝细胞混悬液》作为代偿肝脏功能支持治疗,应用于临床,对重症肝炎具有显著疗效。它在解决肝细胞供体来源方面比同种异体肝细胞更为广泛,更为经济,很有临床推广价值。
Following the identification of severe hepatitis by allogeneic hepatocyte transplantation in Hainan Province, Hainan Provincial Department of Infectious Diseases, the First Hospital of Hainan Province, further designed the heterologous hepatocyte transplantation for the treatment of severe hepatitis in order to solve the donor hepatocytes in order to meet the clinical needs. New research topic. After several animal experiments, made of “heterogeneous liver cell suspension” as a compensatory liver function supportive therapy, applied to clinical, has a significant effect on severe hepatitis. It is more extensive, more economical and more clinically valuable than allogeneic hepatocytes in resolving the source of hepatocyte donors.